These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 31949575)

  • 41. Reduced expression of let-7f activates TGF-β/ALK5 pathway and leads to impaired ischaemia-induced neovascularization after cigarette smoke exposure.
    Dhahri W; Dussault S; Haddad P; Turgeon J; Tremblay S; Rolland K; Desjarlais M; Cáceres-Gorriti KY; Mathieu R; Rivard A
    J Cell Mol Med; 2017 Sep; 21(9):2211-2222. PubMed ID: 28345812
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Circulating miR-126 and miR-130a levels correlate with lower disease risk, disease severity, and reduced inflammatory cytokine levels in acute ischemic stroke patients.
    Jin F; Xing J
    Neurol Sci; 2018 Oct; 39(10):1757-1765. PubMed ID: 30030634
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Combined Use of Circulating miR-133a and NT-proBNP Improves Heart Failure Diagnostic Accuracy in Elderly Patients.
    Guo M; Luo J; Zhao J; Shang D; Lv Q; Zang P
    Med Sci Monit; 2018 Dec; 24():8840-8848. PubMed ID: 30523241
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Serum miR-21 and miR-125b as markers predicting neoadjuvant chemotherapy response and prognosis in stage II/III breast cancer.
    Liu B; Su F; Chen M; Li Y; Qi X; Xiao J; Li X; Liu X; Liang W; Zhang Y; Zhang J
    Hum Pathol; 2017 Jun; 64():44-52. PubMed ID: 28412211
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The N-terminal pro-brain natriuretic peptide as a marker of mitoxantrone-induced cardiotoxicity in multiple sclerosis patients.
    Podlecka-Piętowska A; Kochanowski J; Zakrzewska-Pniewska B; Opolski G; Kwieciński H; Kamińska AM
    Neurol Neurochir Pol; 2014; 48(2):111-5. PubMed ID: 24821636
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of Expression Level of miR-3135b-5p in Blood Samples of Breast Cancer Patients Experiencing Chemotherapy-Induced Cardiotoxicity.
    Zare N; Dana N; Mosayebi A; Vaseghi G; Javanmard SH
    Indian J Clin Biochem; 2023 Oct; 38(4):536-540. PubMed ID: 37746544
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Expression of serum miR-16, let-7f, and miR-21 in patients with hepatocellular carcinoma and their clinical significances.
    Ge W; Yu DC; Li QG; Chen X; Zhang CY; Ding YT
    Clin Lab; 2014; 60(3):427-34. PubMed ID: 24697119
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Serum MicroRNA-99a Helps Detect Acute Rejection in Renal Transplantation.
    Tao J; Yang X; Han Z; Lu P; Wang J; Liu X; Wu B; Wang Z; Huang Z; Lu Q; Tan R; Gu M
    Transplant Proc; 2015; 47(6):1683-7. PubMed ID: 26293033
    [TBL] [Abstract][Full Text] [Related]  

  • 49. ¹⁸F-FDG PET/CT for the Early Evaluation of Response to Neoadjuvant Treatment in Triple-Negative Breast Cancer: Influence of the Chemotherapy Regimen.
    Groheux D; Biard L; Giacchetti S; Teixeira L; Hindié E; Cuvier C; Vercellino L; Merlet P; de Roquancourt A; de Cremoux P; Resche-Rigon M; Espié M
    J Nucl Med; 2016 Apr; 57(4):536-43. PubMed ID: 26697967
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neoadjuvant Chemotherapy in Breast Cancer Patients Induces miR-34a and miR-122 Expression.
    Frères P; Josse C; Bovy N; Boukerroucha M; Struman I; Bours V; Jerusalem G
    J Cell Physiol; 2015 Feb; 230(2):473-81. PubMed ID: 25078559
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Comparison of miRNA signature versus conventional biomarkers before and after off-pump coronary artery bypass graft.
    Pourrajab F; Torkian Velashani F; Khanaghaei M; Hekmatimoghaddam S; Rahaie M; Zare-Khormizi MR
    J Pharm Biomed Anal; 2017 Feb; 134():11-17. PubMed ID: 27866054
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [The predictive values of D-dimer for the early prognosis of the acute myocardial infarction (AMI): a review of 3134 AMI patients].
    Yang J; Li CS
    Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2012 Dec; 24(12):725-9. PubMed ID: 23168200
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of biochemical markers in cardiotoxicity monitoring in patients treated for leukemia.
    Horácek JM; Pudil R; Tichý M; Jebavý L; Strasová A; Praus R; Zák P; Malý J
    Neoplasma; 2005; 52(5):430-4. PubMed ID: 16151589
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Exosomal miRNA profiles of triple-negative breast cancer in neoadjuvant treatment.
    Sueta A; Fujiki Y; Goto-Yamaguchi L; Tomiguchi M; Yamamoto-Ibusuki M; Iwase H; Yamamoto Y
    Oncol Lett; 2021 Dec; 22(6):819. PubMed ID: 34671433
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Identification of Circulating miRNAs Differentially Regulated by Opioid Treatment.
    Toyama K; Kiyosawa N; Watanabe K; Ishizuka H
    Int J Mol Sci; 2017 Sep; 18(9):. PubMed ID: 28926935
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Circulating miR-155, miR-145 and let-7c as diagnostic biomarkers of the coronary artery disease.
    Faccini J; Ruidavets JB; Cordelier P; Martins F; Maoret JJ; Bongard V; Ferrières J; Roncalli J; Elbaz M; Vindis C
    Sci Rep; 2017 Feb; 7():42916. PubMed ID: 28205634
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pharmacodynamic modeling of cardiac biomarkers in breast cancer patients treated with anthracycline and trastuzumab regimens.
    de Vries Schultink AHM; Boekhout AH; Gietema JA; Burylo AM; Dorlo TPC; van Hasselt JGC; Schellens JHM; Huitema ADR
    J Pharmacokinet Pharmacodyn; 2018 Jun; 45(3):431-442. PubMed ID: 29429038
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Circulating pro-angiogenic and anti-angiogenic microRNA expressions in patients with acute ischemic stroke and their association with disease severity.
    Jin F; Xing J
    Neurol Sci; 2017 Nov; 38(11):2015-2023. PubMed ID: 28875333
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Expression of hsa-let-7b-5p, hsa-let-7f-5p, and hsa-miR-222-3p and their putative targets HMGA2 and CDKN1B in typical and atypical carcinoid tumors of the lung.
    Di Fazio P; Maass M; Roth S; Meyer C; Grups J; Rexin P; Bartsch DK; Kirschbaum A
    Tumour Biol; 2017 Oct; 39(10):1010428317728417. PubMed ID: 29017393
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Differential altered expression of let-7a and miR-205 tumor-suppressor miRNAs in different subtypes of breast cancer under treatment with Taxol.
    Asghari F; Haghnavaz N; Shanehbandi D; Khaze V; Baradaran B; Kazemi T
    Adv Clin Exp Med; 2018 Jul; 27(7):941-945. PubMed ID: 30019863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.